Abstract

IntroductionNon-healing of anastomotic leakage can be observed in up to 50% after total mesorectal excision for rectal cancer. This study investigates the efficacy of early transanal closure of anastomotic leakage after pre-treatment with the Endosponge® therapy.MethodsIn this prospective, multicentre, feasibility study, transanal suturing of the anastomotic defect was performed after vacuum-assisted cleaning of the presacral cavity. Primary outcome was the proportion of patients with a healed anastomosis at 6 months after transanal closure. Secondary, healing at last follow-up, continuity, direct medical costs, functionality and quality of life were analysed.ResultsBetween July 2013 and July 2015, 30 rectal cancer patients with a leaking low colorectal anastomosis were included, of whom 22 underwent neoadjuvant radiotherapy. Median follow-up was 14 (7–29) months. At 6 months, the anastomosis had healed in 16 (53%) patients. At last follow-up, anastomotic integrity was found in 21 (70%) and continuity was restored in 20 (67%) patients. Non-healing at 12 months was observed in 10/29 (34%) patients overall, and in 3/14 (21%) when therapy started within three weeks following the index operation. Major LARS was reported in 12/15 (80%) patients. The direct medical costs were €8933 (95% CI 7268–10,707) per patient.ConclusionVacuum-assisted early transanal closure of a leaking anastomosis after total mesorectal excision with 73% preoperative radiotherapy showed that acceptable anastomotic healing rates and stoma reversal rates can be achieved. Early diagnosis and start of treatment seems crucial.

Highlights

  • This study investigates the efficacy of early transanal closure of anastomotic leakage after pre-treatment with the EndospongeÒ therapy

  • A minimal invasive treatment strategy with vacuum-assisted drainage (EVAC) combined with early transanal closure of the anastomotic defect (‘vacuum-assisted early transanal closure’) has been very successful in the early management of leaking ileoanal anastomoses for ulcerative colitis (UC) or familial polyposis (FAP) [14]. These patients have a neorectum made of small bowel instead of colon, and did not receive neoadjuvant radiotherapy. For this reason we aimed to study the efficacy of vacuum-assisted early transanal closure for rectal cancer patients in terms of anastomotic healing, stoma closure, functionality of the neorectum, quality of life (QoL) and treatment-related costs

  • Half of the leaking anastomosis treated with vacuumassisted early transanal closure had healed at 6 months of follow-up

Read more

Summary

Introduction

Non-healing of anastomotic leakage can be observed in up to 50% after total mesorectal excision for rectal cancer. This study investigates the efficacy of early transanal closure of anastomotic leakage after pre-treatment with the EndospongeÒ therapy. Methods In this prospective, multicentre, feasibility study, transanal suturing of the anastomotic defect was performed after vacuum-assisted cleaning of the presacral cavity. Primary outcome was the proportion of patients with a healed anastomosis at 6 months after transanal closure. Secondary, healing at last follow-up, continuity, direct medical costs, functionality and quality of life were analysed. Results Between July 2013 and July 2015, 30 rectal cancer patients with a leaking low colorectal anastomosis were included, of whom 22 underwent neoadjuvant radiotherapy.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call